Abvc Biopharma (ABVC) EBT Margin Growth (3y) (2019 - 2025)
Powered by 
Analysis
Abvc Biopharma (ABVC) EBT Margin Growth (3y) (2019 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 443.00 |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -15,548.00 |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | -484.00 |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 132.00 |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 6,691.00 |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | -2,054.00 |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 9,980.00 |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | -2,399.00 |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | -1.89 Mn |
| 10 | Abvc Biopharma | 25.56 Mn | 25.56 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 866,282.00 |
| Dec 31, 2024 | -5.61 Mn |
| Sep 30, 2024 | 185,662.00 |
| Jun 30, 2024 | 573,019.00 |
| Mar 31, 2024 | -24.25 Mn |
| Dec 31, 2023 | -1.61 Mn |
| Sep 30, 2023 | -1.93 Mn |
| Jun 30, 2023 | -3.56 Mn |
| Mar 31, 2023 | 23,422.00 |
| Dec 31, 2022 | 54,278.00 |
| Sep 30, 2022 | -827,660.00 |
| Jun 30, 2022 | -30,712.00 |
| Mar 31, 2022 | -2.36 Mn |
| Dec 31, 2021 | 15.16 Mn |
| Sep 30, 2021 | 9.93 Mn |
| Jun 30, 2021 | 1.85 Mn |
| Mar 31, 2021 | 758,768.00 |
| Jun 30, 2020 | -45,933.00 |
| Dec 31, 2019 | -84,299.00 |